Saturday 17 October 2026
Export PAIYY’s income statement to Excel — free account
Aesthetic Medical International Hldngs Group Ltd Sponsored ADR
PAIYY Healthcare Medical Care Facilities
In the quarter to June 2025, revenue grew 25,427.4% and EPS grew 76.8%, each against the same quarter a year earlier.
0.01
0.00
0.00%
Follow PAIYY
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | 1 | 2 | 5 | 5 | 5 | 5 |
P/E ratio |
13.37 | 13.37 | 13.37 | 17.35 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.88 | 0.50 | 0.38 | 0.32 | 0.13 | 0.05 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 5.64 | 9.95 | 15.61 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | — | — | (2.58) | (3.29) | (9.56) | (2.48) | (3.39) | (3.56) | (2.30) |
P/Operating CF |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/B ratio |
0.00 | 0.00 | 0.00 | 1.16 | 1.86 | 5.16 | 0.00 | 6.54 | 10.59 | 31.46 |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 12 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 1.71 | 3.64 | 12.96 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 | 0.00 | 0.00 | 1.09 | 0.68 | 0.66 | 0.40 | 0.21 | 0.09 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
0.00 | 0.00 | 0.00 | 7.31 | 12.37 | 21.08 | (29.00) | (15.77) | (10.71) | (6.87) |
EV/FCF |
0.00 | 0.00 | 0.00 | 7.31 | 12.37 | 21.08 | (2.41) | (1.31) | (0.89) | (0.57) |
Quick Ratio |
— | 1.12 | 1.50 | 0.90 | 0.57 | 0.15 | 0.09 | 0.23 | 0.18 | 0.27 |
Current Ratio |
— | 1.71 | 1.65 | 1.00 | 0.68 | 0.21 | 0.14 | 0.27 | 0.22 | 0.31 |
Net Debt/EBITDA |
0.00 | 4.03 | 0.67 | (0.16) | (2.21) | (0.98) | 12.06 | 1.68 | 0.68 | 1.81 |
Debt/Assets |
— | 0.00% | 24.77% | 13.41% | 23.69% | 47.12% | 36.95% | 18.79% | 17.67% | 28.24% |
Debt/Equity |
— | (10.37) | (0.67) | 0.24 | 0.58 | (1.46) | (1.60) | 3.13 | 9.20 | (3.34) |
Asset Turnover |
0.00 | 1.10 | 2.25 | 0.99 | 0.87 | 0.83 | 1.17 | 1.20 | 1.43 | 1.45 |
Operating CF/Net income |
0.98 | (0.93) | (0.12) | 0.64 | 0.00 | (0.09) | 0.99 | (1.98) | (3.99) | 0.23 |
Capex/Depreciation |
0.00 | 0.00 | (2.42) | (0.91) | (0.42) | (0.34) | (0.03) | (0.84) | (0.47) | (0.01) |
Interest Coverage |
9.00 | 18.86 | 7.19 | 0.13 | (6.63) | (12.33) | (2.12) | (2.78) | (0.50) | (1.75) |
| 0.00% | 47.52% | 170.03% | 82.56% | (46.38%) | (554.53%) | 47.61% | 75.81% | (91.69%) | 314.85% | |
| 0.00% | (12.11%) | (74.64%) | 15.55% | (22.60%) | (75.82%) | (13.28%) | (6.59%) | (3.78%) | (10.70%) | |
ROIC |
— | 0.00% | 0.00% | (2.33%) | (22.62%) | (491.74%) | (67.90%) | (44.68%) | (16.40%) | (42.40%) |
Return on Tangible Assets |
0.00% | (24.26%) | (72.82%) | 26.28% | (53.96%) | 847.75% | 52.43% | (849.11%) | 41.79% | 364.52% |
Average Days of Receivables |
0.00 | 24.27 | 74.60 | 35.32 | 48.47 | 24.79 | 19.04 | 17.99 | 14.17 | 25.37 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
60.36% | 56.30% | 58.98% | 70.12% | 82.22% | 94.74% | 56.24% | 54.33% | 45.24% | 45.52% |
Intangible Assets out of Total Assets |
— | 0.00 | 0.10 | 0.17 | 0.20 | 0.06 | 0.07 | 0.07 | 0.08 | 0.06 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 5.50% | 8.76% | 5.49% | 4.11% | 1.10% | 0.00% | 0.00% |
Graham Net Nets |
(0.75) | (0.75) | (0.75) | (0.30) | (0.51) | (0.80) | (2.33) | (1.98) | (3.81) | (6.60) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.44 | 2.51 | 0.00 | 0.00 | — |
Earnings Yield |
7.48% | 7.48% | 7.48% | 5.76% | (29.60%) | (69.83%) | (29.51%) | (63.11%) | (68.16%) | (69.53%) |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% | 17.73% | 10.05% | 6.41% | (72.04%) | (95.18%) | (182.61%) | (333.00%) |
Revenue per Share |
3.67 | 4.30 | 8.40 | 8.18 | 6.00 | 4.55 | 3.65 | 2.20 | 2.20 | 2.10 |
Operating CF per Share |
0.31 | 0.44 | 0.33 | 0.82 | (0.01) | 0.36 | (0.41) | 0.24 | 0.23 | (0.04) |
Capex per Share |
0.00 | 0.00 | (0.86) | (0.72) | (0.30) | (0.23) | (0.01) | (0.18) | (0.09) | 0.00 |
Free Cash Flow per Share |
0.31 | 0.44 | (0.53) | 0.10 | (0.31) | 0.13 | (0.42) | 0.06 | 0.14 | (0.04) |
Cash per Share |
0.00 | 0.67 | 1.12 | 1.45 | 0.35 | 0.28 | 0.07 | 0.20 | 0.13 | 0.19 |
Shareholders Equity per Share |
0.00 | (0.30) | (2.75) | 5.56 | 2.83 | (1.31) | (0.69) | 0.11 | 0.03 | (0.13) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | (0.30) | (2.75) | 5.56 | 2.83 | (1.31) | (0.69) | 0.11 | 0.03 | (0.13) |
Free Cash Flow |
7.45 | 10.55 | (7.22) | 1.56 | (6.66) | 2.76 | (11.41) | 2.66 | 6.81 | (1.76) |
Working Capital |
— | 14.47 | 16.87 | (0.09) | (13.84) | (66.33) | (69.28) | (42.36) | (43.67) | (40.92) |
Capital Expenditures |
(5.90) | (7.05) | (11.74) | (11.00) | (6.54) | (5.16) | (0.25) | (7.83) | (4.27) | (0.06) |
Net Current Asset Value |
— | (57.21) | (97.15) | (27.76) | (58.86) | (100.70) | (88.37) | (58.71) | (54.08) | (58.38) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.10 | 0.09 | 0.05 | 0.05 | 0.00 | 0.08 | 0.04 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.00 | 0.13 | 0.14 | 0.16 | 0.20 | 0.28 | 0.19 | 0.22 | 0.25 | 0.21 |
Cash ROIC |
0.00% | 12.61% | (237.48%) | 1.22% | (6.35%) | 14.28% | (85.62%) | 9.36% | 35.18% | (7.60%) |
Accounts Receivable Turnover |
0.00 | 12.51 | 7.58 | 7.05 | 8.85 | 8.29 | 16.61 | 19.39 | 23.80 | 18.17 |
Accounts Payable Turnover |
20.69 | 21.94 | 16.45 | 17.24 | 14.09 | 11.99 | 7.93 | 7.87 | 9.14 | 9.35 |
Inventory Turnover |
17.09 | 18.13 | 11.10 | 11.45 | 12.01 | 12.19 | 10.53 | 16.07 | 27.19 | 23.06 |
Average Days of Payables |
6.49 | 27.15 | 20.27 | 22.51 | 34.43 | 30.33 | 54.26 | 42.93 | 42.25 | 32.64 |
Days of Inventory on Hand |
(0.19) | 40.45 | 29.85 | 34.55 | 34.10 | 29.66 | 32.33 | 15.77 | 13.02 | 17.66 |
Average Receivables |
— | 8.25 | 15.19 | 17.84 | 14.76 | 12.07 | 6.00 | 4.97 | 4.42 | 5.53 |
Average Payables |
1.58 | 1.58 | 2.38 | 2.32 | 3.67 | 4.86 | 5.90 | 6.47 | 6.36 | 5.78 |
Average Inventory |
1.91 | 1.91 | 3.52 | 3.49 | 4.31 | 4.78 | 4.44 | 3.17 | 2.14 | 2.34 |
Average Assets |
— | 93.65 | 51.11 | 126.87 | 150.97 | 119.92 | 85.31 | 80.21 | 73.43 | 69.35 |
Average Common Equity |
— | (23.87) | (22.44) | 23.89 | 73.57 | 16.40 | (23.80) | (6.98) | 3.03 | (2.36) |
Columns are period end dates